Research-use disclaimer
All products are strictly for laboratory research and in-vitro studies, not for human consumption.
Description
Liraglutide is a long-acting synthetic analog of human GLP-1 (glucagon-like peptide-1), a hormone that regulates blood sugar and appetite. It works by stimulating insulin release, suppressing glucagon secretion, slowing gastric emptying, and significantly reducing appetite. It is widely used for the treatment of type 2 diabetes (brand name: Victoza) and for chronic weight management (brand name: Saxenda). Clinical studies have shown it can produce substantial weight loss and improve glycemic control. It is administered as a once-daily subcutaneous injection. Common side effects are mainly gastrointestinal, such as nausea, vomiting, and constipation, especially during the initial dose escalation period. This content is for research purposes only and is provided solely for reference. It must not be interpreted as health, clinical, or legal advice or guidance.
Product research FAQ
What is this product intended for?
It is supplied strictly for laboratory research and in-vitro studies, not for human consumption.
Is batch documentation available?
Available batch-specific Certificates of Analysis are listed in the COA section on this page.
How should the product be stored?
Follow the storage information shown on this page and the instructions supplied with the specific batch.
